These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34155789)

  • 1. COVID-19 and the liver - Lessons learned.
    Herta T; Berg T
    Liver Int; 2021 Jun; 41 Suppl 1(Suppl 1):1-8. PubMed ID: 34155789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and comorbidities of hepatic diseases in a global perspective.
    Ahmad A; Ishtiaq SM; Khan JA; Aslam R; Ali S; Arshad MI
    World J Gastroenterol; 2021 Apr; 27(13):1296-1310. PubMed ID: 33833483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological mechanisms of liver injury in COVID-19.
    Nardo AD; Schneeweiss-Gleixner M; Bakail M; Dixon ED; Lax SF; Trauner M
    Liver Int; 2021 Jan; 41(1):20-32. PubMed ID: 33190346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.
    Napodano C; Pocino K; Stefanile A; Marino M; Miele L; Gulli F; Basile V; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U
    Scand J Immunol; 2021 Mar; 93(3):e12977. PubMed ID: 32931622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and liver injury in individuals with obesity.
    Lempesis IG; Karlafti E; Papalexis P; Fotakopoulos G; Tarantinos K; Lekakis V; Papadakos SP; Cholongitas E; Georgakopoulou VE
    World J Gastroenterol; 2023 Feb; 29(6):908-916. PubMed ID: 36844135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver dysfunction and SARS-CoV-2 infection.
    Gracia-Ramos AE; Jaquez-Quintana JO; Contreras-Omaña R; Auron M
    World J Gastroenterol; 2021 Jul; 27(26):3951-3970. PubMed ID: 34326607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 in normal, diseased and transplanted liver.
    Signorello A; Lenci I; Milana M; Grassi G; Baiocchi L
    World J Gastroenterol; 2021 May; 27(20):2576-2585. PubMed ID: 34092976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Lizardo-Thiebaud MJ; Cervantes-Alvarez E; Limon-de la Rosa N; Tejeda-Dominguez F; Palacios-Jimenez M; Méndez-Guerrero O; Delaye-Martinez M; Rodriguez-Alvarez F; Romero-Morales B; Liu WH; Huang CA; Kershenobich D; Navarro-Alvarez N
    Semin Liver Dis; 2020 Aug; 40(3):321-330. PubMed ID: 32886936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Damage and Exposure to Toxic Concentrations of Endogenous Retinoids in the Pathogenesis of COVID-19 Disease: Hypothesis.
    Mawson AR; Croft AM; Gonzalez-Fernandez F
    Viral Immunol; 2021; 34(6):376-379. PubMed ID: 33983857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
    Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19, adaptative immune response and metabolic-associated liver disease.
    Miele L; Napodano C; Cesario A; De Magistris A; Pocino K; Basile U; Rapaccini GL; Gasbarrini A; Grieco A
    Liver Int; 2021 Nov; 41(11):2560-2577. PubMed ID: 34555255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and cellular mechanisms of liver dysfunction in COVID-19.
    Huang C; Li Q; Xu W; Chen L
    Discov Med; 2020; 30(160):107-112. PubMed ID: 33382966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and pediatric fatty liver disease: Is there interplay?
    Di Sessa A; Lanzaro F; Zarrilli S; Picone V; Guarino S; Miraglia Del Giudice E; Marzuillo P
    World J Gastroenterol; 2021 Jun; 27(22):3064-3072. PubMed ID: 34168408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients.
    Naeem M; Bano N; Manzoor S; Ahmad A; Munawar N; Razak SIA; Lee TY; Devaraj S; Hazafa A
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology and management of liver injury in patients with COVID-19.
    Yang RX; Zheng RD; Fan JG
    World J Gastroenterol; 2020 Aug; 26(32):4753-4762. PubMed ID: 32921955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight.
    Vasques-Monteiro IML; Souza-Mello V
    World J Gastroenterol; 2021 Apr; 27(16):1738-1750. PubMed ID: 33967554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, patterns, risk factors, and histopathological findings of liver injury in coronavirus disease 2019 (COVID-19): a scoping review.
    Bin Arif T; Khalid S; Siddiqui MS; Hussain H; Sohail H
    Hong Kong Med J; 2021 Jun; 27(1):198-209. PubMed ID: 33122448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liver disease during the pandemic of COVID-19 infection: prediction of the course and tactics of management: A review].
    Maev IV; Osadchuk MA
    Ter Arkh; 2022 Dec; 94(11):1326-1332. PubMed ID: 37167173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.